Arbutus Biopharma Corp. (ABUS)
5.065
-0.02
(-0.30%)
USD |
NASDAQ |
Sep 01, 11:11
Arbutus Biopharma Cash from Operations (TTM) : -24.13M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.13M |
| March 31, 2026 | -34.44M |
| December 31, 2025 | -39.72M |
| September 30, 2025 | -44.63M |
| June 30, 2025 | -59.55M |
| March 31, 2025 | -57.55M |
| December 31, 2024 | -63.46M |
| September 30, 2024 | -70.55M |
| June 30, 2024 | -71.69M |
| March 31, 2024 | -77.15M |
| December 31, 2023 | -85.16M |
| September 30, 2023 | -84.80M |
| June 30, 2023 | -81.25M |
| March 31, 2023 | -81.82M |
| December 31, 2022 | -33.90M |
| September 30, 2022 | -37.49M |
| June 30, 2022 | -34.45M |
| March 31, 2022 | -28.66M |
| December 31, 2021 | -67.16M |
| September 30, 2021 | -63.74M |
| June 30, 2021 | -61.44M |
| March 31, 2021 | -55.38M |
| December 31, 2020 | -52.95M |
| September 30, 2020 | -50.20M |
| June 30, 2020 | -61.20M |
| Date | Value |
|---|---|
| March 31, 2020 | -70.25M |
| December 31, 2019 | -71.38M |
| September 30, 2019 | -74.69M |
| June 30, 2019 | -63.47M |
| March 31, 2019 | -63.22M |
| December 31, 2018 | -66.61M |
| September 30, 2018 | -59.66M |
| June 30, 2018 | -64.44M |
| March 31, 2018 | -52.09M |
| December 31, 2017 | -49.66M |
| September 30, 2017 | -53.69M |
| June 30, 2017 | -50.65M |
| March 31, 2017 | -63.46M |
| December 31, 2016 | -57.48M |
| September 30, 2016 | -59.85M |
| June 30, 2016 | -45.95M |
| March 31, 2016 | -46.19M |
| December 31, 2015 | -52.49M |
| September 30, 2015 | -42.94M |
| June 30, 2015 | -49.04M |
| March 31, 2015 | -39.08M |
| December 31, 2014 | -12.08M |
| September 30, 2014 | -2.981M |
| June 30, 2014 | 0.2296M |
| March 31, 2014 | 5.418M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Insmed, Inc. | -778.92M |
| Pfizer Inc. | 13.40B |
| Gossamer Bio, Inc. | -164.59M |
| Legend Biotech Corp. | -182.95M |